News
Company ImmuPharma PLC
TIDM IMM
Headline Result of AGM
Released 12:12 24-Jul-2009
Number 2504W12
FOR IMMEDIATE RELEASE
London, 24 July 2009
AGM Statement
ImmuPharma plc (LSE : IMM), the specialist pharmaceutical discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were passed.
For further information please contact:
ImmuPharma PLC +44 20 7152 4080
Dimitri Dimitriou, Chief Executive Officer
Richard Warr, Chairman
Buchanan Communications +44 20 7466 5000
Lisa Baderoon
Rebecca Skye Dietrich
Panmure Gordon & Co 44 151 243 0963
Andrew Burnett
© London Stock Exchange plc. All rights reserved